| Breakdown | TTM | Mar 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 64.11B | 63.97B | 62.03B | 56.47B | 50.39B | 46.47B |
| Gross Profit | 15.44B | 15.08B | 14.78B | 12.50B | 11.48B | 10.32B |
| EBITDA | 10.64B | 10.20B | 9.83B | 8.73B | 8.03B | 7.13B |
| Net Income | 5.68B | 5.44B | 4.97B | 4.32B | 3.72B | 3.09B |
Balance Sheet | ||||||
| Total Assets | 52.99B | 53.56B | 47.34B | 42.98B | 39.34B | 36.13B |
| Cash, Cash Equivalents and Short-Term Investments | 24.78B | 24.05B | 7.33B | 17.99B | 15.96B | 329.32M |
| Total Debt | 2.23B | 3.53B | 2.01B | 1.48B | 1.88B | 2.51B |
| Total Liabilities | 18.92B | 19.41B | 17.30B | 16.20B | 15.49B | 15.06B |
| Stockholders Equity | 32.98B | 33.01B | 29.03B | 25.88B | 23.08B | 20.39B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 8.57B | 7.25B | 5.95B | 4.97B | 6.03B |
| Operating Cash Flow | 0.00 | 8.74B | 7.37B | 6.00B | 5.16B | 6.09B |
| Investing Cash Flow | 0.00 | -3.18B | -1.33B | -1.29B | -1.65B | -1.10B |
| Financing Cash Flow | 0.00 | -2.79B | -2.75B | -2.68B | -1.82B | -1.84B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥213.93B | 8.54 | ― | 2.70% | 10.23% | 8.78% | |
76 Outperform | ¥64.49B | 13.11 | ― | 2.65% | 3.62% | 8.01% | |
76 Outperform | ¥148.53B | 22.89 | ― | 1.92% | 7.46% | -8.01% | |
69 Neutral | ¥4.27T | 12.61 | ― | 3.27% | 4.02% | -41.52% | |
67 Neutral | ¥662.38B | 9.47 | 6.07% | 3.69% | 0.48% | 6.92% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
55 Neutral | ¥157.51B | 33.83 | -6.21% | 1.61% | -4.91% | -136.94% |